The Canadian Medical Cannabis Industry

Posted on by

The Canadian medical cannabis industry-leading pioneer Brent has led many of Canada’s significant advancements in patient care and cannabis clinical research. He founded Prairie Plant Systems Inc. (“PPS”) in 1988 which eventually became the sole provider of legal medical cannabis products to Health Canada through the years 2000 to 2013. In 2017, PPS combined with CanniMed Therapeutics to list on TSX (“TSX:CMED”). In March 2018, CanniMed was acquired by Aurora Cannabis Inc. for CAD$1.1-billion. Mr. Zettl’s journey continued when he founded ZYUS Life Sciences Inc. (ZYUS) in January 2019. ZYUS, a Canadian-based life sciences company focuses on the global development and commercialization of phytotherapeutics, including cannabinoid and protein-based formulations. ZYUS is focused exclusively on patients by delivering high-quality, consistent, and GMP-compliant therapeutic formulations to the global medical market.